Please assess the completion status of the following clinical trial:

Trial Title: Continous Lumbar Plexus Block in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Paediatric patients undergoing elective unilateral open hip and femoral surgery requiring general anaesthesia with intubation at the University Hospital - Inselspital in Bern.~* American Society of Anesthesiologist (ASA) physical status 1-3~* 8-16 year old with legal guardians providing written informed consent.~Exclusion Criteria:~* Obesity (BMI 30 kg/m2)~* Infeasibility to use a PCA pump~* Known or suspected infection of the skin at the site of needle puncture area~* Known allergy to ropivacaine~* Severe spine deformity~* Neuromuscular disease~* Coagulopathy.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Treatment group (Type: ACTIVE_COMPARATOR): A bolus injection for LPB of 0.5 ml/kg ropivacaine 3.75 mg/ml (max 40 ml will be performed and the catheter will be placed before surgical interventions. A continuous perineural infusion of 0.2 ml/kg/h ropivacaine 0.2%, starting immediately after initial bolus injection will be then administered
- Control group (Type: NO_INTERVENTION): Patients in the control group (and in the active treatment group) will receive an opioid-based analgesia with a hydromorphone-patient controlled analgesia (PCA) depending on their analgesic demand

Based on this trial design, predict the completion outcome and termination type (if applicable).